Parabilis Medicines, Inc.
Biotechnology Research · Cambridge, MA
S-1 FiledPBLS
Parabilis Medicines, Inc. IPO
Monitoring
S-1 Filed
Priced
Trading
Est. valuation
$100M
Exchange
—
Ticker: PBLS
Status
S-1 Filed
Filed
May 19, 2026
IPO timeline
May 19, 2026
S-1 filed with SEC
Initial registration statement submitted to the Securities and Exchange Commission.
Upcoming
Roadshow & pricing
Company presents to institutional investors. IPO price and share count are finalized.
Upcoming
First-day trading
Shares available on the open market.
Frequently asked questions
When is Parabilis Medicines, Inc. going public?
Parabilis Medicines, Inc. has not yet announced an IPO date or filed a registration statement with the SEC. FireStrike will update this page when official filings or announcements are made.
What is Parabilis Medicines, Inc.'s IPO valuation?
The estimated offering value is $100M. Final valuation will be determined at pricing.
What exchange will Parabilis Medicines, Inc. list on?
No exchange has been officially announced for the Parabilis Medicines, Inc. IPO.
Has Parabilis Medicines, Inc. filed an S-1 with the SEC?
No. As of the most recent data, Parabilis Medicines, Inc. has not filed a Form S-1 or other registration statement with the SEC.
Sources: FireStrike proprietary index · SEC EDGAR